Health Care/Hospital

Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2019 LOS ANGELES, July 15, 2019 /PRNewswire/ -- Significant advances in the global search for blood test technologies for Alzheimer's disease and other dementias were reported at theAlzheimer's Association International Conference (AAIC) ...

2019-07-16 00:30 294

Remote Patient Monitoring to Radically Transform Healthcare Services Using IoT and Big Data

Data-based solutions like predictive technologies to aid in the provision of a holistic service, finds Frost & Sullivan LONDON, July 15, 2019 /PRNewswire/ -- New-age concepts such as the Internet of Medical Things (IoMT), Artificial Intelligence (AI), and Big Data analytics are opening up new ca...

2019-07-15 22:54 286

HNC Celebrated its 10th Anniversary this June in Shanghai

SHANGHAI, July 15, 2019 /PRNewswire/ -- Organized by CCCMHPIE and Sinoexpo Informa Markets, HNC moved to National Exhibition and Convention Center ( Shanghai) this June together with all co-located food industry shows, covering the industry chains from health food, senior care products and service...

2019-07-15 13:41 374

TCEB - Business strengthens Thailand's position as Exhibition Hub of ASEAN

BANGKOK, July 15, 2019 /PRNewswire/ -- The Thailand Convention and Exhibition Bureau (TCEB) - Business' effort to position Thailand as the exhibition hub of ASEAN is bearing fruit with 2019 shaping up to be one of the best years in recent memory. This year seesThailand hosting the 86th UFI Global...

2019-07-15 12:46 392

AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System

SAN JOSE, California, July 15, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k...

2019-07-15 09:17 381

Lifestyle Interventions Provide Maximum Memory Benefit When Combined; And May Offset Elevated Alzheimer's Risk Due To Genetics, Pollution

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2019 LOS ANGELES, July 15, 2019 /PRNewswire/ -- New research reported at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles suggests healthy lifestyle choices — including healthy diet, exercise, and cognitive ...

2019-07-15 08:33 397

First World Longevity Forum and Life Science Conference kicks off in Hezhou, S. China

HEZHOU, China, July 13, 2019 /PRNewswire/ -- The First World Longevity Forum and Life Science Conference (WLF&LSC),organized by Hezhou Municipal People's Government, opened on Friday in Hezhou city, south China's Guangxi Zhuang Autonomous Region. The WLF&LSC aims to build a longevity city brand ...

2019-07-13 00:35 992

Novena Global Lifecare completes US$350 million merger with China's Xingkeduo to expand the NOVU and Xingkeduo brands in China and beyond

* The merger gives Singapore's Novena Global Lifecare access to express haircut business Xingkeduo's proprietary AI-based platform and physical network of nearly 100 stores * Novena Global Lifecare to welcome Xingkeduo's existing shareholders including well-known Chinese venture capital funds...

2019-07-12 11:18 2199

Yuyu Pharma held the campaign for enhancing corporate transparency

SEOUL, South Korea, July 10, 2019 /PRNewswire/ -- Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management system by inviting senior management to its "Self-Compliance Day" workshop.

2019-07-11 16:43 1073

Gilead Sciences to Establish Its Western China Operation Center in Chengdu Hi-tech Zone

CHENGDU, China, July 11, 2019 /PRNewswire/ -- On July 10th, Chengdu Hi-tech Zone and Gilead Sciences inked a strategic cooperation agreement on the Gilead Sciences Western China Operation Center project, which marked the official registration of its westernChina operation center in Chengdu Hi-tec...

2019-07-11 12:23 1022

MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China

ROCKVILLE, Md. and SHANGHAI, July 10, 2019 /PRNewswire/ -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab Biopharma (I-Mab), aChina and U.S....

2019-07-11 04:01 1062

SI Group Announces Focused Sale Of Industrial Resin Business to ASK Chemicals

SCHENECTADY, New York, July 10, 2019 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced today an agreement to sell the majority of its global industrial resin businesses and its B...

2019-07-10 22:00 1186

VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding

AUSTIN, Texas, July 10, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding in the form of a non-repayable cash grant totaling approximately$1.4 million from the Walloon Region, Belgium.  To date, Agen...

2019-07-10 20:30 5055

Spectrum Therapeutics partners with Canadian Mental Health Association's Not Myself Today® initiative

SMITHS FALLS, Ontario and TORONTO, July 10, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to announce a partnership with the Canadian Mental Health Association ("CMHA...

2019-07-10 20:00 5132

iSTAR Medical's MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)

WAVRE, Belgium, July 10, 2019 /PRNewswire/ -- iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial for the MINIj...

2019-07-10 19:44 1012

Healthcare Startup One BioMed closes US$5M Series A Funding Round

SINGAPORE, July 10, 2019 /PRNewswire/ -- One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced today that it has closed aUS$5 million Series A financing round, led bySingapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore's investment ...

2019-07-10 19:12 2032

PATH applauds recognition for frontline treatment of childhood diarrheal disease by the World Health Organization

SEATTLE, July 10, 2019 /PRNewswire/ -- PATH applauds a landmark decision this week by the World Health Organization (WHO) to include a new listing for co-packaged oral rehydration salts (ORS) and zinc sulfate in itsModel List of Essential Medicines (EML) and Model List of Essential Medicines for ...

2019-07-10 18:00 1095

Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline

SINGAPORE, July 10, 2019 /PRNewswire/ -- Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capit...

2019-07-10 15:09 1172

Belgian Meat Office: African Swine Fever: How Belgium Successfully Keeps Its Pork Virus-Free

Belgium deals well with the outbreak of African swine fever (ASF) in September 2018. That is the conclusion of European ASF experts. Belgium succeeds in keeping domestic pigs and captive wild pigs free of ASF contamination -- thus keepingall its pork virus-free and suitable for consumption and ex...

2019-07-10 13:00 1135

CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST

SUZHOU, China, July 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient has been dosed inChina with avapritinib in the ongoing global Phase III VOYAGER clinical trial. This study is designed to evaluate the safety and efficacy of avapritini...

2019-07-10 10:23 5338
12345 ... 722